Dirk Grimm

City:

Heidelberg

Country:

Germany

Published Applications:

Last publication date:

2026-02-12

Top Assignees for applications by Dirk Grimm

The entities that hold a legal rights for patent applications filed by inventor Grimm Dirk:

UNIVERSITÄT HEIDELBERG 1 Heidelberg, Germany
Institut National de la Sante et de la Recherche Medicale 1 Paris, France
MEIRAGTX GENE REGULATION LIMITED 1 London, United Kingdom
Universite d'Evry val d'Essonne 1 Evry-Courcouronnes, France
Genethon 1 Evry-Courcouronnes, France
REVVITY GENE DELIVERY GMBH 1 Gräfelfing, Germany
Universitat Heidelberg 1 Heidelberg, Germany

Recent patent applications by Grimm Dirk

Dirk Grimm from Heidelberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-12

US20260042803A1

Chemistry; metallurgy

VARIANT AAV CAPSID POLYPEPTIDES TARGETING THE EYE

#2 | 2024-11-28

US20240390517A1

Human necessities

AAV8 CAPSID VARIANTS WITH ENHANCED LIVER TARGETING

#3 | 2023-06-08

US20230173102A1

Human necessities

Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders

#4 | 2022-08-25

US20220267797A1

Chemistry; metallurgy

Modified AAV Capsid Proteins for Treatment of Arthritic Disease

#5 | 2021-11-25

US20210363193A1

Chemistry; metallurgy

MODIFIED AAV CAPSID POLYPEPTIDES FOR TREATMENT OF MUSCULAR DISEASES

#6 | 2021-07-01

US20210198328A1

Chemistry; metallurgy

MODULATED CAS-INHIBITORS

#7 | 2020-11-26

US20200370039A1

Chemistry; metallurgy

ADENO-ASSOCIATED VIRUS LIBRARY

#8 | 2020-11-12

US20200354744A1

Chemistry; metallurgy

MODIFIED RAAV CAPSID PROTEIN FOR GENE THERAPY

#9 | 2020-08-27

US20200270603A1

Chemistry; metallurgy

USE OF ANTI-CRISPR POLYPEPTIDES FOR SPECIFIC ACTIVATION OF CAS NUCLEASES

#10 | 2019-04-25

US20190119678A1

Chemistry; metallurgy

MEANS AND METHODS FOR INACTIVATING THERAPEUTIC DNA IN A CELL

InventorID:

2832182 ⎘